NL-OMON45667CompletedNot Applicable
The Personalized Parkinson Project - PPP
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 650
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Prior to enrollment in this clinical investigation, candidates must meet ALL of the following criteria:;* Subject has Parkinson*s disease of <=5 years duration, defined as time since diagnosis made by a neurologist.
- •* Subject is an adult, at least 18 years of age.
- •* Subject can read and understand Dutch.
- •* Subject has completed the CMO-approved Informed Consent.
- •* Subject is willing, competent, and able to comply with all aspects of the protocol, including follow-up schedule and biospecimen collection.
- •* Subject is not a current or previous employee or family member of employees of the institutions involved in the study, including Verily Life Sciences and Radboudumc.
Exclusion Criteria
- •Candidates must be excluded from this study if ANY of the following criteria are met:;* Subject is pregnant or breastfeeding.
- •* Subject has co-morbidities that would hamper interpretation of parkinsonian disability, such as coincident musculoskeletal abnormalities, in the opinion of the Investigator.
- •* Contraindicated for MRI, e.g. claustrophobia, presence of an active implant, pacemaker, insulin pump, neurostimulator, ossicle prosthesis, and/or other medical device or other non-removable metal part incompatible with MRI.
- •* For lumbar puncture:
- •o Allergy to local anesthetic agents
- •o Medical history of compression of spinal cord, current local skin infection at the site of the lumbar puncture, developmental abnormalities in lower spine, blood coagulopathy, anticoagulant medication (Acenocoumarol, Warfarin, Dabigatran).
- •o Clinical (or previous MRI) evidence of structural cerebral abnormalities that are not compatible with the performance of a lumbar puncture such as malignancies, abscess, or obstructive hydrocephalus.
Investigators
Similar Trials
Completed
Not Applicable
The Personalized Parkinson Project - de novo cohort10028037Parkinson's DiseaseNL-OMON49224Radboud Universitair Medisch Centrum144
Completed
Not Applicable
Personalized Parkinson Project - Progressive Supranuclear Palsy cohortProgressive Supranuclear Palsy10028037NL-OMON49320Radboud Universitair Medisch Centrum100
Active, not recruiting
Not Applicable
The Personalized Parkinson Project (PPP)Parkinson DiseaseNCT03364894Radboud University Medical Center520
Recruiting
Not Applicable
The Parkinson*s Progression Markers Initiative (PPMI) Clinical - Establishing a Deeply Phenotyped PD CohortParkinson's diseaseNL-OMON56457Michael J Fox Foundation75
Active, not recruiting
Not Applicable
The Parkinson's Progression Markers Initiative (PPMI)MedDRA version: 14.1Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersParkinson DiseaseEUCTR2010-019894-13-ITMICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH600
